1. Mirazid in treatment of three zoonotic trematodes in Beni-Sweif and Dakhalia Governorates.
- Author
-
Massoud AM, El-Sherbini ET, Mos N, Saleh NM, Abouel-Nour MF, and Morsy AT
- Subjects
- Adolescent, Adult, Aged, Animals, Child, Commiphora, Egypt epidemiology, Fasciola drug effects, Fasciola isolation & purification, Female, Heterophyidae drug effects, Heterophyidae isolation & purification, Humans, Male, Middle Aged, Resins, Plant, Schistosoma drug effects, Schistosoma isolation & purification, Young Adult, Anthelmintics therapeutic use, Plant Extracts therapeutic use, Trematode Infections drug therapy
- Abstract
A total of 60 patients with schistosomiasis (40), fascialiosis (15) and heterophyiasis (5) were selected Beni-Sweif and Mansoura Districts and subjected to history taking, clinical examination, Kato thick smear, sedimentation and hatching test (for schistosomiasis cases) at the beginning of the study, 2 & 3 months after treatment with Oleo-resin of Myrrh (Mirazid) in a dose of 10 mg/kg/day for 6 consecutive days an hour before breakfast. The results showed a significant improvement in symptoms with minimal negligible or no side effects. The cure rates, 2 & 3 months after treatment were 80.7%% & 11.8%% for schistosomiasis, 93.3% & 6.6% for fascioliasis, and 100% for heterophyiasis. The clinical picture of schistosomiasis before treatments were easy fatigability, anorexia, nausea, vomiting, epigastria pain, abdominal distention, right upper guardant pain, colicky abdominal pain, left upper and/or lower guardant pain, abdominal rumbling, dysentery, diarrhea, rectal bleeding, constipation, and alternating bowel habit. Those of fascioliasis were abdominal distention, dripping of saliva, right upper guardant, colicky abdominal pain, weight loss, easy fatigability, intermittent jaundice, anorexia, nausea, vomiting, epigastria, left upper and/or lower quadrant pain, right layer quadrant pain, loin pain, abdominal rumbling, diarrhea, constipation, and alternating bowel habit. The safety and efficacy of C. molmol extract in treating heterophyiasis (100%), fascioliasis (100%) and schistosomiasis (92.5%) were documented.
- Published
- 2010